CRISPR THERAPEUTICS AG (CRSP) Revenue 2016–2025
CRISPR THERAPEUTICS AG (CRSP) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$3.5MFY2025 · since FY2016: $5.2M → $3.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.5M | -90.6% |
| FY2024 | $37.3M | -89.9% |
| FY2023 | $371.2M | +30885.5% |
| FY2022 | $1.2M | -99.9% |
| FY2021 | $915.0M | +127154.9% |
| FY2020 | $719,000 | -99.8% |
| FY2019 | $289.6M | +9169.8% |
| FY2018 | $3.1M | -92.4% |
| FY2017 | $41.0M | +693.9% |
| FY2016 | $5.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice